BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19960504)

  • 1. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
    Faggad A; Budczies J; Tchernitsa O; Darb-Esfahani S; Sehouli J; Müller BM; Wirtz R; Chekerov R; Weichert W; Sinn B; Mucha C; Elwali NE; Schäfer R; Dietel M; Denkert C
    J Pathol; 2010 Feb; 220(3):382-91. PubMed ID: 19960504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of dicer expression in ovarian cancer tissues.
    Pampalakis G; Diamandis EP; Katsaros D; Sotiropoulou G
    Clin Biochem; 2010 Feb; 43(3):324-7. PubMed ID: 19782670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells.
    Suárez Y; Fernández-Hernando C; Pober JS; Sessa WC
    Circ Res; 2007 Apr; 100(8):1164-73. PubMed ID: 17379831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression.
    Tchernitsa O; Kasajima A; Schäfer R; Kuban RJ; Ungethüm U; Györffy B; Neumann U; Simon E; Weichert W; Ebert MP; Röcken C
    J Pathol; 2010 Nov; 222(3):310-9. PubMed ID: 20726036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
    Hu X; Macdonald DM; Huettner PC; Feng Z; El Naqa IM; Schwarz JK; Mutch DG; Grigsby PW; Powell SN; Wang X
    Gynecol Oncol; 2009 Sep; 114(3):457-64. PubMed ID: 19501389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
    Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
    J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours.
    Kim TH; Kim YK; Kwon Y; Heo JH; Kang H; Kim G; An HJ
    Histopathology; 2010 Nov; 57(5):734-43. PubMed ID: 21083603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
    Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro analysis of microRNA processing using recombinant Dicer and cytoplasmic extracts of HeLa cells.
    Leuschner PJ; Martinez J
    Methods; 2007 Oct; 43(2):105-9. PubMed ID: 17889796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. let-7 regulates Dicer expression and constitutes a negative feedback loop.
    Tokumaru S; Suzuki M; Yamada H; Nagino M; Takahashi T
    Carcinogenesis; 2008 Nov; 29(11):2073-7. PubMed ID: 18700235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of miRNA in carcinogenesis and biomarker selection: a methodological view.
    Ahmed FE
    Expert Rev Mol Diagn; 2007 Sep; 7(5):569-603. PubMed ID: 17892365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of microRNA alterations in leukemias and lymphomas.
    Calin GA; Croce CM
    Methods Enzymol; 2007; 427():193-213. PubMed ID: 17720486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Dicer predicts poor survival in colorectal cancer.
    Faber C; Horst D; Hlubek F; Kirchner T
    Eur J Cancer; 2011 Jun; 47(9):1414-9. PubMed ID: 21345667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high-throughput method to monitor the expression of microRNA precursors.
    Schmittgen TD; Jiang J; Liu Q; Yang L
    Nucleic Acids Res; 2004 Feb; 32(4):e43. PubMed ID: 14985473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
    Shi M; Guo N
    Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM; Green AR; Powe DG; Ellis IO
    J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
    Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels.
    Muralidhar B; Goldstein LD; Ng G; Winder DM; Palmer RD; Gooding EL; Barbosa-Morais NL; Mukherjee G; Thorne NP; Roberts I; Pett MR; Coleman N
    J Pathol; 2007 Aug; 212(4):368-77. PubMed ID: 17471471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.